Fruehauf, John P. http://orcid.org/0000-0002-9447-9440
El-Masry, Monica
Osann, Katherine
Parmakhtiar, Basmina
Yamamoto, Maki
Jakowatz, James G.
Funding for this research was provided by:
GlaxoSmithKline (113657 09-53)
Novartis Pharma (113657 09-53)
Article History
Received: 28 May 2018
Accepted: 12 June 2018
First Online: 25 June 2018
Compliance with ethical standards
:
: Research support: Glaxo Smith Kline, Inc. and Novartis, Inc. JP Fruehauf has received financial support from Novartis for speaking at educational symposia and for developing slide decks for educational symposia. No other authors have conflicts of interest.
: This study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The IND for this FDA approved trial is held by JP Fruehauf and UC Irvine.
: This trial was carried out with the approval of the UC Irvine IRB and all patients were required to provided informed consent prior to their participation.